- Donor Egg IVF Technique
- Frozen Embryo Transfer
- Fresh Embryo Transfer
- Others
In Vitro Fertilization Market size valued USD 23.6 billion in 2022 and is poised to grow at a CAGR of 5.6% from 2023-2029. In-vitro fertilization (IVF) is a process where eggs (ovum) from the ovary of a woman are taken and fertilized with sperm in laboratory method, and the embryo (fertilized egg) is sent back to the uterus of the woman. In vitro fertilization is one of the many possible ways to enhance the chance to infertile couple to get pregnancy. IVF usage is depended upon the reasons for infertility. IVF can be an option in case of endometriosis or fallopian tube blockage in the woman or in case of poor quality or low sperm count in man. There are many other treatments for this condition like surgery which can be tried prior to IVF. IVF does not work for the woman who does not have the ovulating capability or the men who unable to produce the proper count of healthy sperms. Increasing in the number of delayed pregnancy cases among the women, growing awareness regarding consequences of infertility, and availability of favourable reimbursement policies, increase technological advancements in IVF process such as capsule in vitro fertilization and embryoscope, growing medical tourism globally are expected to accelerate the demand for in-vitro fertilization market. Rise infertility disorders and gynaecological diseases, increased focus on the innovation of IVF technologies by the clinical research centres, are the factors which are boosting the growth of the global IVF market. However, huge requirements of budget and time to run IVF procedures, difficulty in maintaining the IVF procedure, a risk of multiple conceives by women, ethical issues regarding gender selection, lack of awareness about issues regarding infertility in under-developed countries are expected to hamper the global IVF market growth.
Global In Vitro Fertilization Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
10.3%
Largest Market
North America
Fastest Growing Market
Asia Pacific
In Vitro Fertilization Market Dynamics
Global in vitro fertilization market expected to grow at tremendous growth rate due to the surge in infertility cases across the globe owing to the high prevalence of the infertility diseases globally. As per Centre for Disease Control and Prevention, around 6 Mn women are suffering from infertility problems in U.S. National Health Service (NHS) also reported that about 3 Mn women are suffering from infertility in the UK owing to irregular ovulation, fallopian tubes blockade & endometriosis. Favourable government initiatives have expected to create awareness of innovative IVF technologies. For instance, in India, Bhartiya Mahila Bank & New India Assurance joined together to offer the insurance plan for the infertility treatments irrespective of the financial status of an individual. Which is attracting the infertile couple to adopt IVF, which in turn, boosts the IVF market growth? Expansion of the players in the market are also boosting the growth of the IVF market growth for exemplary, in 2015 November has PALASH launched an innovative unit called as PALASH IVF Solutions Pvt. Ltd.
Asia Pacific Got Significant Share
In Vitro Fertilization Market Regional Analysis
Based on the geographical regions, IVF devices market is segmented as Asia Pacific, Europe, Latin America, North America, and the Middle East & Africa. Increased population with infertility issues, rise in the adoption of advanced IVF technologies over the traditional infertility treatments and availability of favourable insurance coverage for the IVF in some of the U.S. states like New Jersey, New York, Maryland etc. are the factors which are bolstering the North America to be the dominating market in IVF market. Asia Pacific region is anticipated to show fastest growth rate IVF owing to the factors like high maternal age in Japan, one child policy abolishment in China, increased tourism infertility in India & Thailand, increase in adoption of surrogacy are propelling the market growth in Asia Pacific countries.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Global In Vitro Fertilization Market Segmentation
By Technology
By End User
- Fertility Clinics
- Hospitals
- Surgical Centers
- Clinical Research Institutes
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Frequently Asked Questions
The key segments covered in the in vitro fertilization market are: by technology, end-user and geography
The in vitro fertilization market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The in vitro fertilization market key players are: Vitrolife AB (Sweden), Cooper Surgical, Inc. (U.S.), Cook Medical, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Irvine Scientific (U.S.), Genea Limited (Australia), EMD Serono, Inc. (U.S.), IVFtech ApS (Denmark)
| 1. Executive Summary |
| 2. Global In Vitro Fertilization Market Introduction |
| 2.1. Global In Vitro Fertilization Market Taxonomy |
| 2.2. Global In Vitro Fertilization Market Definitions |
| 2.2.1. By Technology |
| 2.2.2. By End User |
| 2.2.3. By Region |
| 3. Global In Vitro Fertilization Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global In Vitro Fertilization Market Dynamic Factors - Impact Analysis |
| 3.6. Global In Vitro Fertilization Market Competition Landscape |
| 4. Global In Vitro Fertilization Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global In Vitro Fertilization Market, By Technology, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 5.1. Donor Egg IVF Technique |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Frozen Embryo Transfer |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Fresh Embryo Transfer |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Others |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global In Vitro Fertilization Market, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 6.1. Fertility Clinics |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Hospitals |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Surgical Centers |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Clinical Research Institutes |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global In Vitro Fertilization Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia-Pacific |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Latin America |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Middle East and Africa |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Global In Vitro Fertilization Market - Opportunity Analysis Index, By Technology, End User, and Region, 2023 - 2029 |
| 8. North America In Vitro Fertilization Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 8.1. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1. Donor Egg IVF Technique |
| 8.1.2. Frozen Embryo Transfer |
| 8.1.3. Fresh Embryo Transfer |
| 8.1.4. Others |
| 8.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1. Fertility Clinics |
| 8.2.2. Hospitals |
| 8.2.3. Surgical Centers |
| 8.2.4. Clinical Research Institutes |
| 8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 8.3.1. USA |
| 8.3.2. Canada |
| 8.4. North America In Vitro Fertilization Market - Opportunity Analysis Index, By Technology, End User, and Country, 2023 - 2029 |
| 8.5. North America In Vitro Fertilization Market Dynamics Trends |
| 9. Europe In Vitro Fertilization Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 9.1. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Donor Egg IVF Technique |
| 9.1.2. Frozen Embryo Transfer |
| 9.1.3. Fresh Embryo Transfer |
| 9.1.4. Others |
| 9.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Fertility Clinics |
| 9.2.2. Hospitals |
| 9.2.3. Surgical Centers |
| 9.2.4. Clinical Research Institutes |
| 9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Germany |
| 9.3.2. UK |
| 9.3.3. France |
| 9.3.4. Spain |
| 9.3.5. Italy |
| 9.3.6. Russia |
| 9.3.7. Rest of Europe |
| 9.4. Europe In Vitro Fertilization Market - Opportunity Analysis Index, By Technology, End User, and Country, 2023 - 2029 |
| 9.5. Europe In Vitro Fertilization Market Dynamics Trends |
| 10. Asia-Pacific In Vitro Fertilization Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 10.1. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Donor Egg IVF Technique |
| 10.1.2. Frozen Embryo Transfer |
| 10.1.3. Fresh Embryo Transfer |
| 10.1.4. Others |
| 10.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Fertility Clinics |
| 10.2.2. Hospitals |
| 10.2.3. Surgical Centers |
| 10.2.4. Clinical Research Institutes |
| 10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. China |
| 10.3.2. India |
| 10.3.3. Japan |
| 10.3.4. ASEAN |
| 10.3.5. Australia & New Zealand |
| 10.3.6. Rest of Asia-Pacific |
| 10.4. Asia-Pacific In Vitro Fertilization Market - Opportunity Analysis Index, By Technology, End User, and Country, 2023 - 2029 |
| 10.5. Asia-Pacific In Vitro Fertilization Market Dynamics Trends |
| 11. Latin America In Vitro Fertilization Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 11.1. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Donor Egg IVF Technique |
| 11.1.2. Frozen Embryo Transfer |
| 11.1.3. Fresh Embryo Transfer |
| 11.1.4. Others |
| 11.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Fertility Clinics |
| 11.2.2. Hospitals |
| 11.2.3. Surgical Centers |
| 11.2.4. Clinical Research Institutes |
| 11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Brazil |
| 11.3.2. Mexico |
| 11.3.3. Argentina |
| 11.3.4. Rest of Latin America |
| 11.4. Latin America In Vitro Fertilization Market - Opportunity Analysis Index, By Technology, End User, and Country, 2023 - 2029 |
| 11.5. Latin America In Vitro Fertilization Market Dynamics Trends |
| 12. Middle East and Africa In Vitro Fertilization Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) (Volume, No. of Procedures) |
| 12.1. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Donor Egg IVF Technique |
| 12.1.2. Frozen Embryo Transfer |
| 12.1.3. Fresh Embryo Transfer |
| 12.1.4. Others |
| 12.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Fertility Clinics |
| 12.2.2. Hospitals |
| 12.2.3. Surgical Centers |
| 12.2.4. Clinical Research Institutes |
| 12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Gulf Cooperation Council (GCC) Countries |
| 12.3.2. Israel |
| 12.3.3. South Africa |
| 12.3.4. Rest of MEA |
| 12.4. MEA In Vitro Fertilization Market - Opportunity Analysis Index, By Technology, End User, and Country, 2023 - 2029 |
| 12.5. MEA In Vitro Fertilization Market Dynamics Trends |
| 13. Competition Landscape |
| 13.1. Strategic Dashboard of Top Market Players |
| 13.2. Company Profiles (Introduction, Financial Analysis, Technology Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 13.2.1. WINFertility |
| 13.2.2. EggFund |
| 13.2.3. CapexMD |
| 13.2.4. GreenSky Patient Solutions |
| 13.2.5. Prosper Healthcare Lending |
| 13.2.6. ACCESS FERTILITY |
| 13.2.7. Houston IVF |
| 13.2.8. Progyny |
| 13.2.9. Medicard |
| 14. Research Methodology |
| 15. Key Assumptions and Acronyms |
- Vitrolife AB (Sweden)
- Cooper Surgical, Inc. (U.S.)
- Cook Medical, Inc. (U.S.)
- Thermo Fisher Scientific, Inc. (U.S.)
- Irvine Scientific (U.S.)
- Genea Limited (Australia)
- EMD Serono, Inc. (U.S.)
- IVFtech ApS (Denmark)